Overview

Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis

Status:
Completed
Trial end date:
2019-09-17
Target enrollment:
Participant gender:
Summary
This study is intented to evaluate the efficacy and safety of MEDITOXIN compared to placebo in treatment of primary axillary hyperhidrosis.
Phase:
Phase 3
Details
Lead Sponsor:
Medy-Tox
Treatments:
Botulinum Toxins, Type A